Production (Stage)
Camp4 Therapeutics Corporation
CAMP
$2.00
-$0.005-0.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 0.15% | -2.22% | -15.30% | -1.21% | |
| Total Depreciation and Amortization | -3.44% | -3.91% | -2.79% | 7.26% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 12.52% | 17.71% | 83.20% | 2.14% | |
| Change in Net Operating Assets | -800.97% | 195.19% | -63.41% | 81.82% | |
| Cash from Operations | -28.21% | 4.20% | -47.89% | 13.68% | |
| Capital Expenditure | -1,760.00% | -8.23% | 100.00% | 86.84% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -1,760.00% | -8.23% | 100.00% | 86.84% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 25.98% | 10.59% | -0.49% | -172.00% | |
| Issuance of Common Stock | -- | 44,080.92% | 3,000.00% | -63.64% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 25.25% | 116,071.43% | -90.15% | -171.25% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -29.54% | 608.82% | -44.73% | 10.83% | |